Bay Labs, a San Francisco, CA-based medical technology company applying artificial intelligence (AI) to cardiovascular imaging, completed a $5.5m Series A financing round.
The round was led by existing investor Khosla Ventures with participation from new investors including Data Collective (DCVC), Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. In conjunction with the funding, Ben Ling, general partner at Khosla Ventures, and Armen Vidian, operating partner at DCVC, will join Bay Labs’ Board of Directors.
The company will use the proceeds to continue clinical validation, accelerate technological development and bring its products to the U.S. market.
Founded in 2013 by Charles Cadieu, CEO, Bay Labs applies artificial intelligence and deep learning to cardiovascular imaging to allow medical professionals of all skill levels to perform and interpret echocardiography. The company has partnered with the Minneapolis Heart Institute and Allina Health, Northwestern Medicine, Duke University School of Medicine, and cardiologists at Stanford University to develop, test and validate deep learning algorithms for echocardiography.
Bay Labs’ products are for investigational use only and currently are not for sale.